Literature DB >> 28693626

Surgical Site Infections After Liver Transplantation: Prospective Surveillance and Evaluation of 250 Transplant Recipients in Canada.

Yoichiro Natori1, Rawan Kassar1, Aled Iaboni1, Seyed M Hosseini-Moghaddam1, James Vu1, Shahid Husain1, Eberhard L Renner1, David Grant1, Coleman Rotstein1.   

Abstract

OBJECTIVE To evaluate the incidence of surgical-site infections (SSIs) in a cohort of liver transplant recipients and to assess risk factors predisposing patients to these infections. DESIGN Prospective observational cohort study. SETTING Single transplant center in Canada. PATIENTS Patients who underwent liver transplantation between February 2011 and August 2014. METHODS Multivariate logistic regression was used to identify independent risk factors for SSIs in liver transplant patients. RESULTS We enrolled 250 liver transplant recipients. The recipients' median age at the time of transplantation was 56 years (range, 19-70 years), and 166 patients (66.4%) were male. Moreover, 47 SSIs were documented in 43 patients (17.2%). Organ-space, superficial, and deep SSIs were noted in 29, 7, and 3 patients, respectively. In addition, 2 patients developed superficial and organ-space SSIs, and another 2 patients were found to have deep as well as organ-space infections. In total, we identified 33 organ-space SSIs (70.2%), 9 superficial SSIs (19.1%), and 5 deep SSIs (10.6%). Factors predictive of SSIs by multivariate analysis were duct-to-duct anastomosis (odds ratio [OR], 3.88; 95% CI, 1.85-8.13; P<.001) and dialysis (OR, 3.57; 95% CI, 1.02-12.50; P=.046). Of the 66 organisms isolated in both deep and organ-space SSIs, 55 (83%) were resistant to cefazolin. CONCLUSIONS Organ-space SSIs are a common complication after liver transplantation. Duct-to-duct anastomosis and dialysis were independent risk factors associated with SSIs. Appropriate perioperative prophylaxis targeting patients with duct-to-duct anastomosis and dialysis while simultaneously providing optimum coverage for the potential pathogens causing SSIs is warranted. Infect Control Hosp Epidemiol 2017;38:1084-1090.

Entities:  

Mesh:

Year:  2017        PMID: 28693626     DOI: 10.1017/ice.2017.131

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  3 in total

Review 1.  Re-examining causes of surgical site infections following elective surgery in the era of asepsis.

Authors:  John C Alverdy; Neil Hyman; Jack Gilbert
Journal:  Lancet Infect Dis       Date:  2020-01-29       Impact factor: 25.071

2.  Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients.

Authors:  Xiaoxia Wu; Guo Long; Weiting Peng; Qiquan Wan
Journal:  Infect Dis Ther       Date:  2022-05-13

3.  Rates and causative pathogens of surgical site infections attributed to liver transplant procedures and other hepatic, biliary, or pancreatic procedures, 2015-2018.

Authors:  Nora Chea; Mathew R P Sapiano; Liang Zhou; Lauren Epstein; Alice Guh; Jonathan R Edwards; Katherine Allen-Bridson; Victoria Russo; Jennifer Watkins; Stephanie M Pouch; Shelley S Magill
Journal:  Transpl Infect Dis       Date:  2021-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.